Workflow
Generative AI drug creation
icon
Search documents
Absci (ABSI) FY Conference Transcript
2025-06-09 13:40
Absci (ABSI) FY Conference June 09, 2025 08:40 AM ET Speaker0 Good morning. I'm Sean McLean, the founder and CEO of Abzai. We're a generative AI drug creation company looking to use generative design, solve some of the toughest problems in biology that still exist, to ultimately get differentiated assets to patients faster. We've always been a data first company. Our original technology was scaling protein protein interactions, going from screening thousands of antibodies to millions. And we've leveraged th ...